Clinical Trial Update: Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of a rebeccamycin analogue in pediatric patients with solid tumors or Non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Neuroblastoma
• Non-hodgkin Lymphoma
• Retinoblastoma
• Sarcoma
• Solid Tumor

Drugs mentioned

• Rebeccamycin analogue (rebeccamycin analogue)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors, Lymphoma | Phase 2 | Status: COMPLETED